Loading...
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
This trial was designed to assess efficacy and safety of erlotinib with sorafenib in the treatment of patients with advanced pancreatic adenocarcinoma. An exploratory correlative study analyzing pretreatment serum samples using a multivariate protein mass spectrometry-based test (VeriStrat®), previo...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BlackWell Publishing Ltd
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4101748/ https://ncbi.nlm.nih.gov/pubmed/24574334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.208 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|